ClinVar Miner

Submissions for variant NM_000019.4(ACAT1):c.*6dup (rs111390656)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
EGL Genetic Diagnostics, Eurofins Clinical Diagnostics RCV000266805 SCV000336091 benign not specified 2015-10-13 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000399813 SCV000366986 likely benign Deficiency of acetyl-CoA acetyltransferase 2016-06-14 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000266805 SCV000918384 benign not specified 2018-02-05 criteria provided, single submitter clinical testing Variant summary: ACAT1 c.*6dupC is located in the untranslated mRNA region downstream of the termination codon. MutationTaster predicts no impact on Poly(A) signal and the variant to be a polymorphism. The variant allele was found at a frequency of 0.0077 in 2132/276872 control chromosomes in the gnomAD database, including 50 homozygotes. The observed variant frequency is approximately 2.67 fold of the estimated maximal expected allele frequency for a pathogenic variant in ACAT1 causing Alpha-methylacetoacetic aciduria phenotype (0.0029), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.*6dupC in individuals affected with Alpha-methylacetoacetic aciduria and no experimental evidence demonstrating its impact on protein function have been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign.
Natera, Inc. RCV000399813 SCV001461800 benign Deficiency of acetyl-CoA acetyltransferase 2020-09-16 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.